-+ 0.00%
-+ 0.00%
-+ 0.00%

Kiniksa Pharmaceuticals Chief Accounting Officer Michael R. Megna Sells $3.42 Million in Common Shares

PUBT·11/03/2026 23:26:52
Listen to the news
Kiniksa Pharmaceuticals Chief Accounting Officer Michael R. Megna Sells $3.42 Million in Common Shares
  • Kiniksa Pharmaceuticals International Chief Accounting Officer Michael R. Megna sold 36,260 Class A Ordinary Shares on October 30, 2026.
  • Reported sale prices ranged from $91.87 to $97.74 per share.
  • Megna also exercised options for 19,895 Class A Ordinary Shares at exercise prices ranging from $10.76 to $17.76.
  • Following the transactions, he directly owned 12,697 Class A Ordinary Shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001464583-26-000010), on November 03, 2026, and is solely responsible for the information contained therein.